loading
전일 마감가:
$118.01
열려 있는:
$118.51
하루 거래량:
548.44K
Relative Volume:
0.60
시가총액:
$7.15B
수익:
$3.99B
순이익/손실:
$463.16M
주가수익비율:
16.65
EPS:
7.1
순현금흐름:
$1.10B
1주 성능:
+4.75%
1개월 성능:
+10.37%
6개월 성능:
-3.12%
1년 성능:
+7.93%
1일 변동 폭
Value
$116.65
$118.72
1주일 범위
Value
$111.20
$119.48
52주 변동 폭
Value
$95.49
$148.06

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Name
명칭
Jazz Pharmaceuticals Plc
Name
전화
353-1-634-7800
Name
주소
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Name
직원
2,800
Name
트위터
@jazzpharma
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
JAZZ's Discussions on Twitter

JAZZ을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
JAZZ
Jazz Pharmaceuticals Plc
118.23 7.14B 3.99B 463.16M 1.10B 7.10
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-15 개시 Deutsche Bank Buy
2025-03-07 업그레이드 UBS Neutral → Buy
2025-02-26 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2025-02-13 업그레이드 Wells Fargo Equal Weight → Overweight
2024-12-12 업그레이드 Morgan Stanley Equal-Weight → Overweight
2024-06-05 개시 Goldman Buy
2024-01-03 개시 Robert W. Baird Outperform
2023-11-27 다운그레이드 UBS Buy → Neutral
2023-09-29 개시 Raymond James Mkt Perform
2023-06-12 재개 Wells Fargo Equal Weight
2022-12-09 업그레이드 Goldman Neutral → Buy
2022-06-14 개시 UBS Buy
2022-04-06 다운그레이드 Goldman Buy → Neutral
2021-11-19 재개 Goldman Buy
2021-10-07 재개 Jefferies Buy
2021-10-05 개시 Citigroup Buy
2021-09-23 개시 Needham Buy
2021-05-19 재개 JP Morgan Overweight
2021-04-07 재개 RBC Capital Mkts Outperform
2021-02-05 재확인 H.C. Wainwright Buy
2021-02-03 업그레이드 Piper Sandler Neutral → Overweight
2021-01-29 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-12-16 개시 UBS Buy
2020-11-03 재확인 H.C. Wainwright Buy
2020-10-09 재확인 H.C. Wainwright Buy
2020-09-14 다운그레이드 Goldman Neutral → Sell
2020-09-14 재개 JP Morgan Overweight
2020-08-06 업그레이드 Morgan Stanley Equal-Weight → Overweight
2020-07-28 업그레이드 Wolfe Research Peer Perform → Outperform
2020-07-23 업그레이드 H.C. Wainwright Neutral → Buy
2020-04-06 개시 Jefferies Buy
2020-03-12 업그레이드 Bernstein Mkt Perform → Outperform
2020-01-08 개시 Goldman Neutral
2019-08-21 다운그레이드 Piper Jaffray Overweight → Neutral
2019-06-11 개시 Barclays Overweight
2019-03-20 개시 SunTrust Buy
2018-12-14 개시 Wolfe Research Peer Perform
2018-11-08 재확인 B. Riley FBR Buy
2018-08-08 재확인 Stifel Buy
2018-07-11 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2018-03-23 재확인 H.C. Wainwright Neutral
2018-03-19 업그레이드 Morgan Stanley Equal-Weight → Overweight
모두보기

Jazz Pharmaceuticals Plc 주식(JAZZ)의 최신 뉴스

pulisher
Jul 25, 2025

Is Jazz Pharmaceuticals plc a good long term investmentOverwhelming financial success - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Jazz Pharmaceuticals plc stockSuperior portfolio returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Idiopathic Hypersomnia Treatment Market Propelled by Rising - openPR.com

Jul 25, 2025
pulisher
Jul 24, 2025

Will Jazz Pharmaceuticals plc stock benefit from AI tech trendsExplosive capital gains - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com

Jul 23, 2025
pulisher
Jul 23, 2025

Jazz Pharmaceuticals (JAZZ) Highlights Growth at Goldman Sachs Healthcare Conference - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Jazz Pharmaceuticals plc stock priceUnmatched market performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Jazz Pharmaceuticals plc Stock Analysis and ForecastRecord-setting profit potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 5, 2025 - 富途牛牛

Jul 22, 2025
pulisher
Jul 21, 2025

Lacklustre Performance Is Driving Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) Low P/E - simplywall.st

Jul 21, 2025
pulisher
Jul 17, 2025

Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025 - GlobeNewswire Inc.

Jul 17, 2025
pulisher
Jul 15, 2025

Jazz Pharmaceuticals Stock Offers Buying Opportunity After Slump, Deutsche Bank Says - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Jazz Pharmaceuticals (JAZZ) Receives Buy Rating from Deutsche Ba - GuruFocus

Jul 15, 2025
pulisher
Jul 15, 2025

Deutsche Bank initiates Jazz Pharmaceuticals stock with Buy rating By Investing.com - Investing.com Nigeria

Jul 15, 2025
pulisher
Jul 15, 2025

Deutsche Bank Initiates Jazz Pharmaceuticals at Buy With $152 Price Target - MarketScreener

Jul 15, 2025
pulisher
Jul 14, 2025

What makes Jazz Pharmaceuticals plc stock price move sharplyFree Capital Allocation Plans - beatles.ru

Jul 14, 2025
pulisher
Jul 14, 2025

Ireland: Renee Gala elected CEO at Jazz Pharma - Investors in Healthcare

Jul 14, 2025
pulisher
Jul 11, 2025

Jazz names new CEO; Ultragenyx, Mereo shares slide on trial update - BioPharma Dive

Jul 11, 2025
pulisher
Jul 11, 2025

Jazz Pharmaceuticals Appoints Renee Gala as New CEO - The Globe and Mail

Jul 11, 2025
pulisher
Jul 11, 2025

Jazz Pharmaceuticals names Renee Gala as next CEO By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 11, 2025

Innoviva, Inc. shares rise 2.05% premarket after Jazz Pharmaceuticals announces CEO succession plan. - AInvest

Jul 11, 2025
pulisher
Jul 11, 2025

Jazz Pharmaceuticals names Renee Gala as next CEO - Investing.com Australia

Jul 11, 2025
pulisher
Jul 11, 2025

1 Profitable Stock with Solid Fundamentals and 2 to Brush Off - Yahoo Finance

Jul 11, 2025

Jazz Pharmaceuticals Plc (JAZZ) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
자본화:     |  볼륨(24시간):